Performance of conventional laboratory tests and Xpert MTB/RIF in the diagnosis of tuberculosis
Abstract
The laboratory diagnosis of tuberculosis (TB) represents a continuous challenge due to the variability and complexity of the required clinical samples. Although molecular technologies have considerably improved diagnostic accuracy, their combined use with traditional methods like microscopy and bacterial culture remains a subject of debate. This study aims to compare the performance of microscopy, bacterial culture on Löwenstein-Jensen medium, and the molecular Xpert MTB/RIF test in diagnosing pulmonary and extrapulmonary TB. In this retrospective study, conducted over a period from January 2016 to January 2023, data were collected from pulmonary TB and extrapulmonary TB samples of patients hospitalized in the pneumonology departments of the Bihor County Emergency Hospital. The study included 1796 patients, of whom 85.2% had samples collected from the respiratory tract. The variability of sensitivity and specificity depending on the type of sample indicates the need for a differentiated approach in diagnosis. The results show that the Xpert MTB/RIF test detected a higher number of positive cases (16%) compared to microscopy (9%) and bacterial culture (15%). Statistical analysis revealed a high sensitivity and specificity of Xpert MTB/RIF, suggesting superior accuracy compared to traditional methods. Our conclusions underline the importance of the Xpert MTB/RIF as a valuable tool in the diagnosis of TB, but it is recommended to use it in combination with other methods to ensure a complete and efficient diagnosis.
Ethics Approval
The study protocol was approved by the Ethical Committee of the Bihor County Emergency Clinical Hospital (protocol no. 11325 dated 2024/04/15).
References
- World Health Report. Global tuberculosis report 2024. Available online: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024.
- Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med 2018;6:299-314. DOI: https://doi.org/10.1016/S2213-2600(18)30057-2
- Yue X, Wang H, Jin D, et al. Healthcare data gateways: found healthcare intelligence on blockchain with novel privacy risk control. J Med Syst 2016;40:218. DOI: https://doi.org/10.1007/s10916-016-0574-6
- Procop GW. Laboratory diagnosis and susceptibility testing for Mycobacterium tuberculosis. Microbiol Spectr 2016;4. doi: 10.1128/microbiolspec.TNMI7-0022-2016. DOI: https://doi.org/10.1128/microbiolspec.TNMI7-0022-2016
- Cioboata R, Biciusca V, Olteanu M, Vasile CM. COVID-19 and tuberculosis: unveiling the dual threat and shared solutions perspective. J Clin Med 2023;12:4784. DOI: https://doi.org/10.3390/jcm12144784
- Patra K, Batabyal S, Mandal K, et al. Tuberculosis and COVID-19: a combined global threat to human civilization. Clin Epidemiol Glob Health 2022;15:101031. DOI: https://doi.org/10.1016/j.cegh.2022.101031
- Abdulgader SM, Okunola AO, Ndlangalavu G, et al. Diagnosing tuberculosis: what do new technologies allow us to (not) do? Respiration 2022;101:797-813. DOI: https://doi.org/10.1159/000525142
- Machado D, Couto I, Viveiros M. Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infect Genet Evol 2019;72:93-112. DOI: https://doi.org/10.1016/j.meegid.2018.11.021
- Orina F, Mwangi M, Meme H, et al. Intrinsic and extrinsic factors associated with sputum characteristics of presumed tuberculosis patients. PLoS One 2019;14:e0227107. DOI: https://doi.org/10.1371/journal.pone.0227107
- Bartolomeu-Gonçalves G, Souza JM, Fernandes BT, et al. Tuberculosis diagnosis: current, ongoing, and future approaches. Diseases 2024;12:202. DOI: https://doi.org/10.3390/diseases12090202
- Boldi MO, Denis-Lessard J, Neziri R, et al. Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: a 10-year retrospective study. Front Cell Infect Microbiol 2023;13:1131241. DOI: https://doi.org/10.3389/fcimb.2023.1131241
- Ramachandra V, Brammacharry U, Muralidhar A, et al. Assess the diagnostic accuracy of GeneXpert to detect mycobacterium tuberculosis and rifampicin-resistant tuberculosis among presumptive tuberculosis and presumptive drug resistant tuberculosis patients. Microbiol Res 2024;15:91-108. DOI: https://doi.org/10.3390/microbiolres15010006
- Yang Q, Han J, Shen J, et al. Diagnosis and treatment of tuberculosis in adults with HIV. Medicine 2022;101:e30405. DOI: https://doi.org/10.1097/MD.0000000000030405
- Agizew T, Chihota V, Nyirenda S, et al. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial. BMC Infect Dis 2019;19:1058. DOI: https://doi.org/10.1186/s12879-019-4697-5
- Nadeem Z, Iqbal J, Kausar S, et al. Comparative analysis of the efficacies of the genexpert and solid culture media techniques in the diagnosis of Mycobacterium tuberculosis. Arch Razi Inst 2022;77:2065-72.
- Gong X, He Y, Zhou K, et al. Efficacy of Xpert in tuberculosis diagnosis based on various specimens: a systematic review and meta-analysis. Front Cell Infect Microbiol 2023;13:1149741. DOI: https://doi.org/10.3389/fcimb.2023.1149741
- Dragonieri S, Bikov A, Capuano A, et al. Methodological aspects of induced sputum. Adv Respir Med 2023;91:397-406. DOI: https://doi.org/10.3390/arm91050031
- Metcalf T, Soria J, Montano SM, et al. Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis. PLoS One 2018;13:e0198695. DOI: https://doi.org/10.1371/journal.pone.0198695
- Vilchèze C, Kremer L. Acid-fast positive and acid-fast negative mycobacterium tuberculosis: the koch paradox. Microbiol Spectr 2017;5: 10.1128/microbiolspec.tbtb2-0003-2015. DOI: https://doi.org/10.1128/microbiolspec.TBTB2-0003-2015
- Rodrigues da Costa R, Silva MR, Augusto CJ, Gonçalves Leite IC. Fast, simple and cheap: method modified from conventional cultivation for tuberculosis diagnosis allows seeding on Löwenstein-Jensen of any swab-embedded pulmonary samples decontaminated with sodium hydroxide. Trans R Soc Trop Med Hyg 2022;116:523-30. DOI: https://doi.org/10.1093/trstmh/trab162
- McHugh ML. Interrater reliability: the kappa statistic. Biochem Med 2012;22:276-82. DOI: https://doi.org/10.11613/BM.2012.031
- Çorbacıoğlu ŞK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value. Turk J Emerg Med 2023,23:195-8. DOI: https://doi.org/10.4103/tjem.tjem_182_23
- Shah B, Shah SC, Kakadia P, et al. The clinician, the lab and the patient: Understanding lab diagnostics to eradicate tuberculosis. Indian J Tuberc 2023;70:42-8. DOI: https://doi.org/10.1016/j.ijtb.2022.03.006
- Elbrolosy AM, El Helbawy RH, Mansour OM, Latif RA. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis. BMC Microbiol 2021;21:144. DOI: https://doi.org/10.1186/s12866-021-02210-5
- Kabir S, Parash MTH, Emran NA, et al. Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of pulmonary tuberculosis. PLoS One 2021;16:e0251858. DOI: https://doi.org/10.1371/journal.pone.0251858
- Fernandes P, Ma Y, Gaeddert M, et al. Sex and age differences in Mycobacterium tuberculosis infection in Brazil. Epidemiol Infect 2018;146:1503-10. DOI: https://doi.org/10.1017/S0950268818001450
- Asare KK, Azumah DE, Adu-Gyamfi CO, et al. Comparison of microscopic and xpert MTB diagnoses of presumptive mycobacteria tuberculosis infection: retrospective analysis of routine diagnosis at Cape Coast Teaching Hospital. BMC Infect Dis 2024;24:660. DOI: https://doi.org/10.1186/s12879-024-09566-9
- Rathish B, Wilson A, Pillay R, et al. A bundled approach to pulmonary tuberculosis testing: experience from a tertiary care centre in south India. Cureus 2019;11:e6042. DOI: https://doi.org/10.7759/cureus.6042
- de Almeida IN, de AssisFigueredo LJ, Soares VM, et al. Evaluation of the mean cost and activity based cost in the diagnosis of pulmonary tuberculosis in the laboratory routine of a high-complexity hospital in Brazil. Front Microbiol 2017;8:249. DOI: https://doi.org/10.3389/fmicb.2017.00249
- Chaudhary R, Bhatta S, Singh A, et al. Diagnostic performance of GeneXpert MTB/RIF assay compared to conventional Mycobacterium tuberculosis culture for diagnosis of pulmonary and extrapulmonary tuberculosis, Nepal. Narra J 2021;1:e33. DOI: https://doi.org/10.52225/narraj.v1i2.33
- Mai NT, Thwaites GE. Recent advances in the diagnosis and management of tuberculous meningitis. Curr Opin Infect Dis 2017;30:123-8. DOI: https://doi.org/10.1097/QCO.0000000000000331
- Gopalaswamy R, Dusthackeer VNA, Kannayan S, Subbian S. Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance. J Respir 2021;1:141-64. DOI: https://doi.org/10.3390/jor1020015
- Ulain N, Ali A, Khan M, et al. Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates. PLoS One 2022;17:e0276064. DOI: https://doi.org/10.1371/journal.pone.0276064
- Atnafu A, Desta K, Girma S, et al. Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. PLoS One 2022;17:e0265499. DOI: https://doi.org/10.1371/journal.pone.0265499
- Singh BK, Sharma SK, Sharma R, et al. Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis. PloS One 2017;12:e0182988. DOI: https://doi.org/10.1371/journal.pone.0182988
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.